| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 695,137 | 628,666 | 605,053 | 628,254 | | Cost of Revenue | 52,058 | 50,902 | 64,299 | 67,815 | | | Gross Profit | 643,079 | 577,764 | 540,754 | 560,439 | | | Operating Expenses | | Research Development | 193,362 | 218,499 | 181,248 | 468,568 | | Selling General and Administrative | 192,512 | 176,312 | 173,440 | 200,202 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 21,111 | 22,667 | 23,625 | 26,125 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 236,094 | 160,286 | 162,441 | (134,456) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 35,403 | 29,248 | 50,063 | 35,319 | | Earnings Before Interest And Taxes | 271,168 | 189,690 | 211,733 | (100,103) | | Interest Expense | 466 | 527 | 464 | 469 | | Income Before Tax | 270,702 | 189,163 | 211,269 | (100,572) | | Income Tax Expense | 53,887 | 46,329 | 48,386 | 48,690 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 216,815 | 142,834 | 162,883 | (149,262) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 216,815 | 142,834 | 162,883 | (149,262) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $216,815 | $142,834 | $162,883 | ($149,262) |
|
0.04% Nasdaq 
0.43%
Income Statement
